We are live on ! Find out more
AKTX

Akari Therapeutics
AKTX

14 hedge funds and large institutions have $1.18M invested in Akari Therapeutics in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more capital invested

Capital invested by funds: $644K → $1.18M (+$537K)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

8% more funds holding

Funds holding: 13 → 14 (+1)

0.05% more ownership

Funds ownership: 0.04% → 0.09% (+0.05%)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cresset Asset Management
Illinois
+$782K
2
VF
Virtu Financial
New York
+$21.9K
3
TSS
Two Sigma Securities
New York
+$19.2K
4
IAA
Independent Advisor Alliance
North Carolina
+$10.6K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$210K
2
OFW
Omnia Family Wealth
Florida
-$33.3K
3
Renaissance Technologies
Renaissance Technologies
New York
-$20.4K
4
EWA
EverSource Wealth Advisors
Alabama
-$4.2K
5
UBS Group
UBS Group
Switzerland
-$2.02K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cresset Asset Management
Illinois
$831K +$782K +20,102 +4,370%
PAI
2
Palo Alto Investors
California
$147K – – –
HighTower Advisors
3
HighTower Advisors
Illinois
$80K – – –
OFW
4
Omnia Family Wealth
Florida
$28.7K -$33.3K -856 -55%
Cerity Partners
5
Cerity Partners
New York
$23.9K – – –
VF
6
Virtu Financial
New York
$22K +$21.9K +563 New
TSS
7
Two Sigma Securities
New York
$20K +$19.2K +494 New
IAA
8
Independent Advisor Alliance
North Carolina
$11K +$10.6K +272 New
ACM
9
Accent Capital Management
Ohio
$10.1K – – –
NA
10
NewEdge Advisors
Louisiana
$6.87K – – –
CPG
11
Cornerstone Planning Group
New Jersey
$285 – – –
Bank of America
12
Bank of America
North Carolina
$152 – – –
UBS Group
13
UBS Group
Switzerland
$61 -$2.02K -52 -96%
TC
14
Truvestments Capital
Florida
$51 – – –
EWA
15
EverSource Wealth Advisors
Alabama
$44 -$4.2K -108 -99%
Morgan Stanley
16
Morgan Stanley
New York
$3 – – –
SM
17
Sabby Management
Florida
– -$210K -4,495 Closed
Renaissance Technologies
18
Renaissance Technologies
New York
– -$20.4K -435 Closed

AKTX Hedge Fund Activity: Q3 2025 in Review

14 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q3 2025, worth a combined $1.18M — up 83% from $644K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AKTX positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Cresset Asset Management, adding an estimated $782K. The largest seller was Sabby Management, exiting entirely with an estimated $210K sold.

  • 14 institutional investors held Akari Therapeutics (AKTX) as of Q3 2025, up from 13 in Q2 2025.
  • Funds reported $1.18M of Akari Therapeutics stock for Q3 2025, up 83% quarter-over-quarter.
  • 3 funds opened new Akari Therapeutics positions in Q3 2025 and 2 closed out, a net change of +1 holder.
  • The largest Akari Therapeutics buyer in Q3 2025 was Cresset Asset Management, an estimated $782K added.
  • The largest Akari Therapeutics seller in Q3 2025 was Sabby Management, an estimated $210K sold.

Based on aggregated 13F filings for Q3 2025.